Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01271244 · ClinicalTrials.gov registry record · Phase 4
Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder
A Phase 4 study of PTSD, sponsored by VA Nebraska Western Iowa Health Care System.
- Completed
- Registry status
- Phase 4
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT01271244 is a Phase 4 study of PTSD that has completed, run by VA Nebraska Western Iowa Health Care System. The registered enrollment target is 26 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01271244, a Phase 4 study of PTSD, has completed, sponsored by VA Nebraska Western Iowa Health Care System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The study looked at relationship between escitalopram and heart rate variability and QT variability in veterans with PTSD.
Conditions Studied
Interventions
- DRUG Escitalopram
Study Locations (1)
Nebraska
- Omaha Veterans Affairs Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01271244
The ClinicalTrials.gov registry entry for NCT01271244 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (91% lower). The listed sponsor is VA Nebraska Western Iowa Health Care System, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Escitalopram is the first listed.
NCT01271244 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT01271244 about?
NCT01271244 is a clinical study titled "Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder". The study looked at relationship between escitalopram and heart rate variability and QT variability in veterans with PTSD.
What is the current status of trial NCT01271244?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 26 participants. The study started on 2008-06. Estimated completion is 2013-06.
What conditions does trial NCT01271244 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT01271244?
The interventions under investigation include: Escitalopram (DRUG).
Who is sponsoring clinical trial NCT01271244?
This trial is sponsored by VA Nebraska Western Iowa Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01271244 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD
RECRUITING · Phase 4
-
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
COMPLETED · Phase 4
-
Paroxetine Treatment in Outpatients With Comorbid PTSD and Substance Dependence
COMPLETED · Phase 4
-
Minocycline for Treatment of Posttraumatic Stress Disorder in Veterans
COMPLETED · Phase 4
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.